SNCA and Parkinson disease: Parkinson’s disease (PD) is a progressive neurodegenerative disease characterized by the loss of dopaminergic neuronal cells located in the substantia nigra and the presence of protein inclusions called Lewy bodies, which include insoluble alpha-synuclein aggregates [1,2,3].